Change from baseline in disease severity according to participants ‐ not measured · people with eczema
The review found no eligible studies for this question.
1 finding from 1 review
Participant satisfaction ‐ not measured · people with eczema
The review found no eligible studies for this question.
1 finding from 1 review
Number of participants reporting an adverse event · people with eczema
1 finding from 1 review
Change from baseline in disease severity as assessed by the investigators · people with eczema
1 finding from 1 review
Number of participants who experienced a flare · people with eczema
Moisturisers may leads to lower number of participants who experienced a flare compared with no treatment (no moisturiser) (low certainty).
1 finding from 1 review
Amount of corticosteroids used · people with eczema
1 finding from 1 review
Change from baseline in health‐related quality of life · people with eczema
1 finding from 1 review
The proportion of participants developing any signs and symptoms of OIHD (incident cases) measured by clinical scores (IGA) or hand dermatitis scores (e.g. HECSI, Manuscore), or both, as rated by the investigator (physician/nurse) or the participa... · workers at risk of occupational irritant hand dermatitis
Moisturisers showed no clear difference in the proportion of participants developing any signs and symptoms of… compared with no treatment (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · workers at risk of occupational irritant hand dermatitis
1 finding from 1 review
Change from baseline in disease severity as assessed by the participants (number of participants who considered their skin to have improved) · people with eczema
All moisturisers may leads to higher change from baseline in disease severity as assessed by the… compared with vehicle, placebo or no moisturiser (low certainty).
1 finding from 1 review
Participant satisfaction · people with eczema
All moisturisers showed no clear difference in participant satisfaction compared with vehicle, placebo or no moisturiser (low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · people with eczema
All moisturisers showed no clear difference in number of participants reporting an adverse event compared with vehicle, placebo or no moisturiser (moderate certainty).
1 finding from 1 review
Change from baseline in disease severity as assessed by the investigators · people with eczema
1 finding from 1 review
Number of participants who experienced a flare · people with eczema
All moisturisers probably leads to lower number of participants who experienced a flare compared with vehicle, placebo or no moisturiser (moderate certainty).
1 finding from 1 review
Total amount of topical corticosteroids used · people with eczema
1 finding from 1 review
Change from baseline in health‐related quality of life · people with eczema
1 finding from 1 review
Change from baseline in disease severity as assessed by the participants (number of participants who considered their skin to have improved) · people with eczema
Oat‐containing moisturisers showed no clear difference in change from baseline in disease severity as assessed by the… compared with vehicle or no moisturiser (low certainty).
1 finding from 1 review
Participant satisfaction · people with eczema
It is very uncertain whether oat‐containing moisturisers changes participant satisfaction compared with vehicle or no moisturiser (very low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · people with eczema
Oat‐containing moisturisers showed no clear difference in number of participants reporting an adverse event compared with vehicle or no moisturiser (low certainty).
1 finding from 1 review
Change from baseline in disease severity as assessed by the investigators · people with eczema
1 finding from 1 review